Recombinant human N-acetylglucosaminyltransferase 2 from human embryonic kidney cell

Cat. No.: X23-06-YM262

Recombinant human N-acetylglucosaminyltransferase 2 from human embryonic kidney cell

Synonym: MGAT2

Product Size
25 μg; 100 μg; 200 μg
Price
Datasheet
MSDS
Properties
Description
Recombinant human N-acetylglucosaminyltransferase 2 from human embryonic kidney cell is responsible for recognizing an unmodified GlcNAc residue installed by MGAT1 in the alpha 3 arm of the trimannosy core of N-glycans and transferring a second GlcNAc residue to the alpha 6 arm of the structure, thereby initiating the conversion of oligomannose type N-glycan to the complex type N-glycan.
Molecular Weight
46-54 kDa
Purity
>80%, determined by SDS-PAGE.
Source
Human embryonic kidney cell
Form
Solution
Applications
Recombinant human N-acetylglucosaminyltransferase 2 from human embryonic kidney cell is useful for the investigation of type II carbohydrate-deficient glycoprotein syndrome and abnormal brain development.
Storage
Store at -20°C.
Related Products

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.